Table 2

Impact of SARS-CoV-2 on mortality, PEI and DM

SARS-CoV-2 negativeSARS-CoV-2 positive*
12-Month mortality after discharge†RefHR: 1.89 (0.93–3.85, p=0.078)
DM‡RefOR: 0.61 (0.13–2.96, p=0.541)
PEI§RefOR: 1.11 (0.44–2.79, p=0.828)
  • *HR for mortality, and OR for DM and PEI, 95% CIs, and p value from adjusted logistic regression models.

  • †Mortality adjusted for premorbid ECOG performance status and revised Atlanta classification.

  • ‡DM adjusted for sex and revised Atlanta classification.

  • §PEI adjusted for age, sex, premorbid ECOG performance status and revised Atlanta classification.

  • DM, diabetes mellitus; ECOG, Eastern Cooperative Oncology Group; PEI, pancreatic exocrine insufficiency.